Literature DB >> 15106294

Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom.

Neal A Halsey1, Jorge Pinto, Francisco Espinosa-Rosales, María A Faure-Fontenla, Edson da Silva, Aamir J Khan, A D Webster, Philip Minor, Glynis Dunn, Edwin Asturias, Hamidah Hussain, Mark A Pallansch, Olen M Kew, Jerry Winkelstein, Roland Sutter.   

Abstract

OBJECTIVE: To estimate the rate of long-term poliovirus excretors in people known to have B-cell immune deficiency disorders.
METHODS: An active search for chronic excretors was conducted among 306 persons known to have immunoglobulin G (IgG) deficiency in the United States, Mexico, Brazil, and the United Kingdom, and 40 people with IgA deficiency in the United States. Written informed consent or assent was obtained from the participants or their legal guardians, and the studies were formally approved. Stool samples were collected from participants and cultured for polioviruses. Calculation of the confidence interval for the proportion of participants with persistent poliovirus excretion was based on the binomial distribution.
FINDINGS: No individuals with long-term excretion of polioviruses were identified. Most participants had received oral poliovirus vaccine (OPV) and almost all had been exposed to household contacts who had received OPV. Polioviruses of recent vaccine origin were transiently found in four individuals in Mexico and Brazil, where OPV is recommended for all children.
CONCLUSION: Although chronic poliovirus excretion can occur in immunodeficient persons, it appears to be rare.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15106294      PMCID: PMC2585894     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  28 in total

1.  Long-term excretion of vaccine-derived poliovirus by a healthy child.

Authors:  Javier Martín; Kofi Odoom; Gráinne Tuite; Glynis Dunn; Nicola Hopewell; Gill Cooper; Catherine Fitzharris; Karina Butler; William W Hall; Philip D Minor
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples.

Authors:  Natalia I Romanenkova; Sophie Guillot; Nadejda R Rozaeva; Radu Crainic; Maina A Bichurina; Francis Delpeyroux
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

Review 3.  Polio eradication in India: the way forward.

Authors:  S K Mittal; Joseph L Mathew
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 1.967

4.  Modeling population immunity to support efforts to end the transmission of live polioviruses.

Authors:  Kimberly M Thompson; Mark A Pallansch; Radboud J Duintjer Tebbens; Steve G Wassilak; Stephen L Cochi
Journal:  Risk Anal       Date:  2012-09-17       Impact factor: 4.000

5.  OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic.

Authors:  Alexandre Manirakiza; Emmanuella Picard; Richard Ngbale; Didier Menard; Ionela Gouandjika-Vasilache
Journal:  BMC Res Notes       Date:  2010-05-18

6.  Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.

Authors:  Chen-Fu Yang; Hour-Young Chen; Jaume Jorba; Hui-Chih Sun; Su-Ju Yang; Hsiang-Chi Lee; Yhu-Chering Huang; Tzou-Yien Lin; Pei-Jer Chen; Hiroyuki Shimizu; Yorihiro Nishimura; Andi Utama; Mark Pallansch; Tatsuo Miyamura; Olen Kew; Jyh-Yuan Yang
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 7.  The role of prolonged viral gastrointestinal infections in the development of immunodeficiency-related enteropathy.

Authors:  Annick A J M van de Ven; David P Hoytema van Konijnenburg; Annemarie M J Wensing; Joris M van Montfrans
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

8.  Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients.

Authors:  Imen Ben-Mustapha; Khaoula Ben-Farhat; Naouel Guirat-Dhouib; Emna Dhemaied; Beya Larguèche; Meriem Ben-Ali; Jalel Chemli; Jihène Bouguila; Lamia Ben-Mansour; Fethi Mellouli; Monia Khemiri; Mohamed Béjaoui; Mohamed-Ridha Barbouche
Journal:  J Clin Immunol       Date:  2013-01-13       Impact factor: 8.317

9.  Sequential asymptomatic enterovirus infections in a patient with major histocompatibility complex class II primary immunodeficiency.

Authors:  Nadia Driss; Fethi Mellouli; Ahlem Ben Yahia; Henda Touzi; Mohamed-Ridha Barbouche; Henda Triki; Mohamed Bejaoui
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

10.  High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies.

Authors:  Nadia Driss; Imen Ben-Mustapha; Fethi Mellouli; Ahlem Ben Yahia; Henda Touzi; Mohamed Bejaoui; Mohamed Ben Ghorbel; Henda Triki; Mohamed-Ridha Barbouche
Journal:  Clin Vaccine Immunol       Date:  2012-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.